HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veli-Matti Leppänen Selected Research

Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

1/2022Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veli-Matti Leppänen Research Topics

Disease

6Neoplasms (Cancer)
01/2019 - 12/2010
3Lymphedema (Milroy Disease)
01/2022 - 01/2020
3Edema (Dropsy)
01/2020 - 08/2013
3Inflammation (Inflammations)
04/2016 - 01/2013
2Adenoma (Adenomas)
01/2021 - 10/2018
1Thrombocytopenia (Thrombopenia)
11/2023
1Infections
11/2023
1Hyperplasia
01/2020
1Breast Neoplasms (Breast Cancer)
07/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
10/2017
1Body Weight (Weight, Body)
04/2016
1Weight Loss (Weight Reduction)
04/2016
1Obesity
04/2016
1Glaucoma
09/2014
1Heart Failure
07/2014
1Cardiomegaly (Heart Hypertrophy)
07/2014
1Pathologic Processes
08/2013
1Neoplasm Metastasis (Metastasis)
08/2013
1Hemangioma (Angioma)
01/2013
1Pathologic Neovascularization
02/2010
1Parkinson Disease (Parkinson's Disease)
07/2007

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor CIBA
01/2022 - 02/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 12/2010
3Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
09/2014 - 02/2010
2AngiopoietinsIBA
01/2022 - 10/2017
2TIE Receptors (TIE Receptor Tyrosine Kinases)IBA
01/2022 - 10/2017
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2020
2Vascular Endothelial Growth Factor BIBA
04/2016 - 07/2014
2Vascular Endothelial Growth FactorsIBA
08/2013 - 12/2010
1VaccinesIBA
11/2023
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1IntegrinsIBA
01/2020
1taxaneIBA
07/2019
1Bevacizumab (Avastin)FDA Link
07/2019
1Angiogenesis InhibitorsIBA
01/2019
1Sorafenib (BAY 43-9006)FDA Link
01/2019
1Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA
10/2018
1Transcription Factors (Transcription Factor)IBA
10/2018
1CateninsIBA
10/2018
1LipidsIBA
04/2016
1Insulin (Novolin)FDA Link
04/2016
1Placenta Growth FactorIBA
08/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2013
1AntibodiesIBA
12/2010
1Blocking AntibodiesIBA
12/2010
1LigandsIBA
12/2010
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2010
1Oxidopamine (6 Hydroxydopamine)IBA
07/2007

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
07/2019
1Therapeutics
12/2010